Related references
Note: Only part of the references are listed.A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
Joseph Kuo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
Joseph Kuo et al.
FRONTIERS IN PHARMACOLOGY (2019)
Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
Jung Gyu Park et al.
SCIENTIFIC REPORTS (2019)
Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model
Francois Briand et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Cyclophilin D promotes tubular cell damage and the development of interstitial fibrosis in the obstructed kidney
Weiping Hou et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization
Giuseppe Mazza et al.
SCIENTIFIC REPORTS (2017)
Cyclophilin A was revealed as a candidate marker for human oral submucous fibrosis by proteomic analysis
Xiaohui Hou et al.
CANCER BIOMARKERS (2017)
Engineering in vitro models of hepatofibrogenesis
Giuseppe Mazza et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice
Susan B. Liu et al.
FASEB JOURNAL (2016)
Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection
Magnus Joakim Hansson et al.
CHEMISTRY & BIOLOGY (2015)
Recent advancement of molecular mechanisms of liver fibrosis
Ekihiro Seki et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia
Tatiana Iordanskaia et al.
MOLECULAR MEDICINE (2015)
The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I - Induced Myocarditis
David Heinzmann et al.
PLOS ONE (2015)
Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever
Vinicio Carloni et al.
LIVER INTERNATIONAL (2014)
Abnormal Type I Collagen Post-translational Modification and Crosslinking in a Cyclophilin B KO Mouse Model of Recessive Osteogenesis Imperfecta
Wayne A. Cabral et al.
PLOS GENETICS (2014)
The types of hepatic rnyofibroblasts contributing to liver fibrosis of different etiologies
Jun Xu et al.
FRONTIERS IN PHARMACOLOGY (2014)
A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
Masato Fujii et al.
MEDICAL MOLECULAR MORPHOLOGY (2013)
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Juliane S. Troeger et al.
GASTROENTEROLOGY (2012)
Fibrosis in alcoholic and nonalcoholic steatohepatitis
Ramon Bataller et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes
Shawna M. Pyott et al.
HUMAN MOLECULAR GENETICS (2011)
N-methyl-4-isoleucine cyclosporine attenuates CCl4-induced liver fibrosis in rats by interacting with cyclophilin B and D
Hui Wang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Structural and Biochemical Characterization of the Human Cyclophilin Family of Peptidyl-Prolyl Isomerases
Tara L. Davis et al.
PLOS BIOLOGY (2010)
NIM811 (N-Methyl-4-isoleucine Cyclosporine), a Mitochondrial Permeability Transition Inhibitor, Attenuates Cholestatic Liver Injury but Not Fibrosis in Mice
Hasibur Rehman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells
Motoyuki Kohjima et al.
LIVER INTERNATIONAL (2007)
Hepatic stellate cells and the reversal of fibrosis
Tatiana Kisseleva et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator
B Miao et al.
JOURNAL OF LIPID RESEARCH (2004)
Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes
K Kon et al.
HEPATOLOGY (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
P Hammel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
